abrdn Healthcare Investors (NYSE:HQH - Get Free Report)'s stock price passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $18.79 and traded as high as $19.64. abrdn Healthcare Investors shares last traded at $19.4890, with a volume of 111,728 shares changing hands.
abrdn Healthcare Investors Stock Down 0.6%
The firm's 50-day moving average price is $18.79 and its 200 day moving average price is $18.97.
abrdn Healthcare Investors Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, February 20th were given a $0.63 dividend. This represents a $2.52 annualized dividend and a dividend yield of 12.9%. The ex-dividend date was Friday, February 20th. This is a boost from abrdn Healthcare Investors's previous quarterly dividend of $0.57.
Hedge Funds Weigh In On abrdn Healthcare Investors
Institutional investors have recently added to or reduced their stakes in the stock. NWF Advisory Services Inc. increased its position in abrdn Healthcare Investors by 34.1% during the 3rd quarter. NWF Advisory Services Inc. now owns 138,988 shares of the financial services provider's stock worth $2,566,000 after purchasing an additional 35,326 shares in the last quarter. Penserra Capital Management LLC increased its position in abrdn Healthcare Investors by 15.4% during the 3rd quarter. Penserra Capital Management LLC now owns 1,198,855 shares of the financial services provider's stock worth $22,130,000 after purchasing an additional 159,618 shares in the last quarter. Guerra Advisors Inc acquired a new position in abrdn Healthcare Investors during the 3rd quarter worth approximately $39,000. Prevail Innovative Wealth Advisors LLC increased its position in abrdn Healthcare Investors by 13.1% during the 3rd quarter. Prevail Innovative Wealth Advisors LLC now owns 117,129 shares of the financial services provider's stock worth $2,162,000 after purchasing an additional 13,592 shares in the last quarter. Finally, Wedbush Securities Inc. increased its position in abrdn Healthcare Investors by 37.0% during the 3rd quarter. Wedbush Securities Inc. now owns 29,955 shares of the financial services provider's stock worth $553,000 after purchasing an additional 8,087 shares in the last quarter. 32.60% of the stock is currently owned by institutional investors and hedge funds.
About abrdn Healthcare Investors
(
Get Free Report)
abrdn Healthcare Investors NYSE: HQH is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Healthcare Investors wasn't on the list.
While abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.